Skip to main content
  • Careers
  • Contact
  • en   it

Navigazione principale

  • About us
  • GMP Solutions
    • Our services
    • Viral Vector
    • Genetically Modified Cells
    • Facilities
  • PIPELINE
    • Our products
    • CAR-T platform
    • CAR-NK
  • Investors
  • Governance
  • News & Events

Navigazione principale

  • About us
  • GMP Solutions
    • Our services
    • Viral Vector
    • Genetically Modified Cells
    • Facilities
  • PIPELINE
    • Our products
    • CAR-T platform
    • CAR-NK
  • Investors
  • Governance
  • News & Events

MolMed is now part of AGC Biologics

Learn more

AGC Biologics

Investors

Financial reports
Financial reports ▾

Menu Investors Sidebar

  • Stock information
  • Press releases
  • Notices
  • Presentations
  • Shareholders’ structure
  • Financial reports
  • Analyst coverage
  • IPO
  • OPA
  • Shareholders meetings
  • Events
  • Internal dealing
  • Financial Calendar
  • LATEST
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014

July 30, 2020 - 17:46

Half-year financial report - 30 06 2020

DOWNLOAD

May 14, 2020 - 16:49

Interim Management Report at March 31st, 2020

DOWNLOAD

April 6, 2020 - 17:43

Annual Financial Report at December 31, 2019 (English translation for convenience)

DOWNLOAD

November 20, 2019 - 17:25

Interim financial report as of September 30 2019

DOWNLOAD

August 1, 2019 - 07:16

Half year financial report IH19

DOWNLOAD

May 15, 2019 - 08:15

Interim financial report as of March, 31st 2019

DOWNLOAD

April 12, 2019 - 08:01

Annual Report as of December, 31st 2018

DOWNLOAD

September 30, 2018 - 09:07

Interim financial report as of September, 30th 2018

DOWNLOAD

June 30, 2018 - 12:08

Half-year financial report as of June, 30th 2018

DOWNLOAD

March 31, 2018 - 08:07

Interim financial report as of March, 31st 2018

DOWNLOAD

December 31, 2017 - 07:04

Annual financial report 2017

DOWNLOAD

September 30, 2016 - 13:05

Interim financial report as of 30 September 2016

DOWNLOAD

June 30, 2016 - 08:06

Half-year financial report as of 30 June 2016

DOWNLOAD

December 31, 2015 - 10:01

Annual financial report 2015

DOWNLOAD

September 30, 2015 - 07:06

Interim financial report as of 30 September 2015

DOWNLOAD

June 30, 2015 - 13:06

Half-year financial report as of 30 June 2015

DOWNLOAD

March 31, 2015 - 12:00

Interim financial report as of March, 31st 2015

DOWNLOAD

December 31, 2014 - 13:00

Annual financial report 2014

DOWNLOAD

September 30, 2014 - 12:00

Interim financial report as of 30 September 2014

DOWNLOAD

June 30, 2014 - 10:00

Half-year financial report as of 30 June 2014

DOWNLOAD

March 31, 2014 - 11:00

Interim financial report as of 31 March 2014

DOWNLOAD

Subscribe to press releases

By subscribing to this newsletter, you confirm that you have read the Privacy Policy and agree to receive MolMed's press releases

Contacts

Investor Relations & Communication Department
Telefono: +39 02 21277.321
E-mail: investor.relations@molmed.com

Investors

Dear Users, we would like to inform you that, as of 30 September, AGC Biologics S.p.A. (formerly MolMed S.p.A.) is no longer listed on the Milan Stock Exchange and has become part of the AGC Biologics Group. For any information on the company and the group, you are kindly invited to consult the websitewww.agcbio.com.
The contents present on this portal (www.molmed.com) are updated until the date of September 30, 2020 and will be available for the time frame foreseen by applicable regulations. 
In addition, the "work with us" section is still active, while the contact details are no longer accessible.

Leading the way in Cell and Gene therapy

MolMed S.p.A.
Via Olgettina, 58
20132 Milano, Italy
+39 0221277.1
info@molmed.com
Privacy & Cookie Policy

About us

About us ▾

aboutus

  • Business model
  • Our Team
  • Scientific advisory board
  • Hystory
  • Careers

Pipeline

Pipeline ▾

pipeline

  • Our products
  • CAR-T platform
  • CAR-NK

GMP Solutions

GMP Solutions ▾

GMP Solutions footer ENG

  • Our services
  • Viral Vectors
  • Genetically Modified Cells
  • Facilities

Investors

Investors ▾

Investors

  • Stock informations
  • Presentations
  • Notices
  • Events
  • Financial Calendar

Governance

Governance ▾

Governance

  • Corporate governance model
  • Corporate governance rules
  • Business ethics
  • Corporate governance reports

News & Events

News ▾

News

  • News & Events
MolMed S.p.A. Via Olgettina, 58 - 20132 Milano, Italia | Tel. +39 0221277.1 - Fax +39 02 21277.325 | info@molmed.com - www.molmed.com
Capitale Sociale € 21.819.020,83 i.v. - REA n.1506630 - N. iscrizione Reg. Imprese di Milano - C. F. e P. IVA 11887610159